NASA Prebreathe Study

PHASE1SuspendedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 5, 2025

Primary Completion Date

October 30, 2025

Study Completion Date

October 30, 2025

Conditions
Decompression Sickness
Interventions
OTHER

Altitude

"Subjects will be exposed to simulated altitude (30,000 ft, 4.3 psia) in a hypobaric chamber. This is the same ambient pressure to which astronauts are exposed during EVA (space walks)."

DRUG

100% Oxygen

Oxygen pre-breathing prior to altitude or simulated high altitude exposure is routinely used by the Air Force, NASA and organizations such as Duke Medical Center to prevent and treat decompression sickness as well as for treatment of patients. Oxygen used for this study is medical grade.

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Aeronautics and Space Administration (NASA)

FED

lead

Duke University

OTHER